Top 10 Insider Sales Last Month

7. Tempus AI, Inc. (NASDAQ:TEM)

Total value of insider sales in February: $256,330,551.71

Market capitalization: $7.84 billion

Seventh among the top 10 insider sales last month is a technology-driven healthcare company Tempus AI. Based in Chicago, Illinois, Tempus AI is focused on leveraging artificial intelligence and machine learning to enhance precision medicine. The company holds one of the largest global databases of clinical and molecular information, supported by a platform designed to make this data both readily available and actionable.

Recently, Tempus AI finalized the acquisition of a big player in genetic testing, Ambry Genetics, in a deal valued at $375 million in cash and $225 million in stock.

In February, eight insiders sold a total of $256.33 million worth of Tempus AI shares at an average price of $78.29 per share. Since the beginning of the year, the stock rose 28.02% and is now trading at $43.22 per share. Since the company’s IPO in June 2024, the stock returned 7.44% to its investors.

For the full 2024, Tempus AI disclosed revenue of $693 million, up by 30% year-over-year. In the fourth quarter, its revenue grew 35.7% to $200.7 million. The company attributed this strong revenue growth to market adoption of both genomic testing and data services.

Based on 11 analysts’ estimates, Tempus AI is a “Buy” with a 12-month price target of $61.22, according to StockAnalysis.